Knownwell's Groundbreaking Clinical Outcomes Report on Obesity
In a significant development for the field of obesity management, knownwell has released its inaugural Clinical Outcomes Report, shedding light on the effectiveness of its comprehensive metabolic health program. This report, based on real-world data from 1,807 patients treated over a two-year period, from February 2023 to February 2025, showcases promising results that could reshape treatment approaches for obesity.
Key Findings from the Report
The findings within the report are striking, showcasing the potential for effective long-term weight management in patients suffering from obesity. Key takeaways include:
- - Average Weight Loss: Participants lost an impressive average of 15.9% of their body weight. More importantly, 88% of patients managed to lose at least 5%, while 74% achieved a 10% reduction in their weight, highlighting the program's effectiveness.
- - Lean Mass Preservation: One of the most notable aspects of knownwell’s approach is the 50% lower lean mass loss compared to benchmarks set by published GLP-1 clinical trials. This outcome suggests that knownwell's method not only focuses on weight loss but also on preserving vital muscle mass, pivotal for overall health.
- - Sustained Results: An astonishing 97% of participants maintained their weight loss over a year, with minimal weight regain of 5% or less. This statistic stands in stark contrast to the almost negligible results reflected in national averages.
- - Diverse Patient Engagement: The data indicates consistent outcomes across various obesity classes and care modalities, including virtual, hybrid, and in-person care methods.
As the use of GLP-1 medications sees a sharp upturn across the United States, health systems and insurance providers are grappling with questions regarding treatment durability, adherence, and the long-term return on investment. Knownwell’s innovative hybrid care model, which fuses obesity medicine, primary care, and nutritional advice, is specifically designed to optimize medicine's effectiveness, safeguard against muscle loss, and bolster patient adherence, thus enhancing overall health outcomes.
Comprehensive Care Approach
Dr. Angela Fitch, Chief Medical Officer and Co-Founder of knownwell, emphasized the complexity of treating obesity, stating that addressing the issue demands a far more comprehensive approach than simply prescribing medication. According to Fitch, “Obesity is a chronic, complex disease, and our patients deserve comprehensive, longitudinal care that addresses the whole person, not just their weight.
This insightful approach necessitates a multidisciplinary team encompassing physicians, advanced practice clinicians, registered dietitians, pharmacists, nurses, and health coaches, which sets knownwell apart from conventional medication-focused telehealth platforms. This model allows patients to manage their metabolic conditions holistically, a crucial factor in tackling broader health concerns within a unified medical framework.
Patients benefit immensely from this integration, resulting in a decrease in fragmented care and a substantial enhancement of treatment effectiveness.
Long-term engagement and a substantial return on investment for health systems and payers are now within reach, as evidenced by the outcomes discussed in the report.
The specifics of knownwell's Clinical Outcomes Report provide vital evidence that the integration of comprehensive care strategies can lead to not only healthier patients but also a more sustainable model for managing obesity. For a detailed view of the Clinical Outcomes Report, interested parties can access the publication at
knownwell.co/publication.
In conclusion, as healthcare systems adapt to the increasing prevalence of obesity, knownwell stands out as a frontrunner in the development of holistic treatment methodologies that prioritize enduring weight management and overall patient wellness. Through continuous innovation and a steadfast commitment to patient care, knownwell is indeed redefining the standard for obesity treatment.